# Using T-Cell Alloreactivity and Chimerism to Guide Immunosuppression Minimization in Intestinal Transplantation

> **NCT04804891** · PHASE1 · RECRUITING · sponsor: **Columbia University** · enrollment: 6 (estimated)

## Conditions studied

- Intestinal Transplantation

## Interventions

- **BIOLOGICAL:** Cell Therapy

## Key facts

- **NCT ID:** NCT04804891
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-10-22
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2026-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04804891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04804891, "Using T-Cell Alloreactivity and Chimerism to Guide Immunosuppression Minimization in Intestinal Transplantation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04804891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*